Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction
- PMID: 2704821
- DOI: 10.1148/radiology.171.2.2704821
Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction
Abstract
The depiction of contrast material-enhanced lesions with magnetic resonance imaging can be improved by using chemical shift imaging (CSI) for lipid suppression in combination with gadolinium diethylenetriaminepentaacetic acid (DTPA) enhancement. Gd-DTPA enhancement was combined with the hybrid technique for lipid suppression, which provides water-only images without increasing imaging time or postprocessing. Lesions with high signal intensity due to paramagnetic relaxation enhancement are easily distinguished from low-intensity lipid, which would otherwise dominate T1-weighted images. Preliminary studies were performed to compare Gd-DTPA-CSI images with conventional postcontrast T1-weighted images. In patients examined for orbital, pituitary, and musculoskeletal abnormalities, the Gd-DTPA-CSI technique enabled improved detection and finer anatomic staging of lesions. In theory, a similar result can be achieved by using any chemical shift-selective method that results in true lipid suppression together with paramagnetic contrast agents that generate high signal intensity. This general approach should be applicable to clinical studies in other tissues or organ systems dominated by lipid, including the pelvis, mediastinum, and breast.
Similar articles
-
Gadolinium-DTPA enhancement of an optic nerve and chiasmal meningioma.J Clin Neuroophthalmol. 1989 Jun;9(2):122-5. J Clin Neuroophthalmol. 1989. PMID: 2526157
-
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.Radiology. 1987 May;163(2):421-6. doi: 10.1148/radiology.163.2.3562821. Radiology. 1987. PMID: 3562821
-
MR contrast enhancement of intracranial lesions with Gd-DTPA.Radiol Clin North Am. 1988 Jul;26(4):873-87. Radiol Clin North Am. 1988. PMID: 3289078 Review.
-
Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.Radiographics. 1989 Jul;9(4):587-98. doi: 10.1148/radiographics.9.4.2756189. Radiographics. 1989. PMID: 2756189
-
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).Magn Reson Imaging Clin N Am. 1996 Feb;4(1):61-72. Magn Reson Imaging Clin N Am. 1996. PMID: 8673717 Review.
Cited by
-
Dynamic contrast-enhanced MR imaging of the entire breast with spectral-selective inversion fast three dimensional sequence.MAGMA. 1998 Dec;7(2):69-75. doi: 10.1007/BF02592231. MAGMA. 1998. PMID: 9951767
-
Osteoid osteoma and osteoblastoma: MRI appearances and the significance of ring enhancement.Eur Radiol. 1996;6(3):291-6. doi: 10.1007/BF00180597. Eur Radiol. 1996. PMID: 8797998
-
Contrast-enhanced fat saturation magnetic resonance imaging for studying the pathophysiology of osteonecrosis of the hips.Skeletal Radiol. 1992;21(6):375-9. doi: 10.1007/BF00241816. Skeletal Radiol. 1992. PMID: 1523433
-
Fat-suppression contrast-enhanced MRI in the failed back surgery syndrome: a prospective study.Neuroradiology. 1995 Jan;37(1):51-7. doi: 10.1007/BF00588520. Neuroradiology. 1995. PMID: 7708190
-
New applications of MR contrast agents in neuroradiology.Neuroradiology. 1990;32(5):421-38. doi: 10.1007/BF00588476. Neuroradiology. 1990. PMID: 2259437
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical